Fig. 2From: Osimertinib-induced hearing loss: an uncommon aftereffect of a novel drug—a case reportAudiogram 1 year after the audiogram in Fig. 1, hearing loss progressed into bilateral severe to profound sensorineural hearing lossBack to article page